Clinical trial
Prospective Evaluation of a Parenteral Omega-3 Fatty Acid Preparation (Omegaven™) in Therapy of Patients With TPN-Induced Cholestasis
NCT00826020 is registered in ClinicalTrials.gov with University of Nebraska as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Evaluation of a Parenteral Omega-3 Fatty Acid Preparation (Omegaven™) in Therapy of Patients With TPN-Induced Cholestasis
- Lead sponsor
- University of Nebraska
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 1, 2009
- Completion date
- October 6, 2017
- Enrollment
- 72 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cholestasis, parenteral nutrition associated liver disease pnald